KIVOKAST-AD
Description_Effects
KIVOKAST-AD is a combination medicine designed to treat and manage respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. It contains Desloratadine, Acebrophylline sustained-release, and Montelukast, each working in a unique way to improve breathing and reduce allergy symptoms. Desloratadine is an antihistamine that relieves allergy symptoms like sneezing, itching, and runny nose by blocking the effects of histamine, a substance released during allergic reactions. Acebrophylline is a bronchodilator and mucolytic agent that helps relax and open the airways, making breathing easier, and also helps in thinning mucus to clear the lungs. Montelukast works by blocking leukotrienes, chemicals responsible for inflammation and narrowing of the airways, which helps to prevent asthma attacks and reduce swelling in the nasal passages. Together, these ingredients provide effective control of breathing difficulties, airway inflammation, and allergic symptoms, helping patients breathe better and reduce episodes of respiratory distress. It is important to take KIVOKAST-AD exactly as prescribed by a healthcare professional and maintain regular medical follow-ups to monitor progress. This combination therapy supports long-term management and improved quality of life for those with chronic respiratory issues.
